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Abstract
Background—The discovery of functional classes of long noncoding RNAs (lncRNAs) has
expanded our understanding of the variety of RNA species that exist in cells. In the heart,
lncRNAs have been implicated in the regulation of development, ischemic and dilated
cardiomyopathy, and myocardial infarction. Nevertheless, there is a limited description of
expression profiles for these transcripts in human subjects.
Methods and Results—We obtained left ventricular tissue from human patients undergoing
cardiac surgery and used RNA sequencing to describe a lncRNA profile. We then identified a list
of lncRNAs that were differentially expressed between pairs of samples before and after the
ischemic insult of cardiopulmonary bypass. The expression of some of these lncRNAs correlates
with ischemic time. Coding genes in close proximity to differentially expressed lncRNAs as well
as coding genes that have coordinated expression with these lncRNAs are enriched in functional
categories related to myocardial infarction including: heart function, metabolism, the stress
response, and the immune system.
Conclusions—We describe a list of lncRNAs that are differentially expressed after ischemia in
the human heart. These genes are predicted to function in pathways consistent with myocardial
injury. As a result, lncRNAs may serve as novel diagnostic and therapeutic targets for ischemic
heart disease.
Clinical Trial Registration—https://clinicaltrials.gov/; Unique Identifier: NCT00985049.
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Introduction
Next generation sequencing has expanded our knowledge of the diversity of RNA
transcribed by the human genome. We now know that the dogma of genetic information that
flows from DNA to RNA and then protein is much more complex than originally
envisioned. These new technologies have enabled us to uncover many different categories of
RNA transcripts, and most of them are not translated into proteins. These noncoding RNAs
are generally classified into either small RNAs, including microRNAs, or long noncoding
RNAs (lncRNAs).1 LncRNAs are RNA transcripts >200 nucleotides in length that have low
potential to encode proteins. To date, there are over 50,000 identified lncRNAs in the human
genome with some variation based on different annotations. They can be found throughout
the genome including within introns of coding genes, antisense transcripts of coding genes,
overlapping exons of coding genes or their promoters, or between genes (so called long
intergenic RNAs or lincRNAs).2 Unfortunately, little is known about the function of these
transcripts, in part because of the infancy of the field, but also due to the lack of
conservation among lncRNAs, the complexity of their isoforms, and limited insight into
shared motifs. Nevertheless, studies that have examined the pattern of lncRNA transcription
and experiments that have characterized a select number of lncRNAs suggest many potential
biological roles. The position of many lncRNAs in promoter and enhancer regions makes
them well poised to control transcriptional activation and repression.3 Some lncRNAs serve
as scaffolds for chromatin modifying factors and thus regulate epigenetics. Other lncRNAs,
particularly those anti-sense lncRNAs, have been shown to regulate the expression of coding
genes by directly binding to components of mRNAs and/or miRNAs.4
Differential and tissue specific expression of lncRNAs has been documented for many
natural processes such as development5 and physiology6 along with several pathological
conditions such as cardiovascular disease.2 Some groups have described the changes in
lncRNAs that occur following myocardial infarction in animal models. For example, in a
study of acute myocardial ischemia in mice, novel heart specific lncRNAs were identified
that are associated with physiological characteristics of heart function and likely mediate the
post injury stress response.7 Human studies, on the other hand, have been limited. One
group identified differentially expressed lncRNAs between hearts with either ischemic or
non-ischemic cardiomyopathy compared to healthy donors and demonstrated that the
expression of some of these lncRNAs returned to levels consistent with healthy hearts
following administration of mechanical support.8 Even more, some studies have also looked
at lncRNAs in circulating mononuclear cells9 and in the plasma10 of patients after
myocardial infarction. Nevertheless, to date there are no studies that have specifically
examined the lncRNA profile of acute ischemia in the human heart.
We hypothesized that ischemia alters the expression of lncRNAs in the human heart. During
surgery requiring cardiopulmonary bypass (CPB), the heart undergoes many changes similar
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to acute myocardial ischemia.11 We obtained left ventricular (LV) biopsies from a large
group of cardiac surgical patients before and after CPB. RNA from these paired samples was
sequenced and annotated with known transcripts. We were able to identify a population of
differentially expressed lncRNAs and investigated putative functions. In so doing we
describe the first lncRNA profile of acute ischemia in the human LV.
Methods
Patients and tissue samples
We prospectively enrolled eighty-five patients undergoing non-emergent aortic valve
replacement surgery with CPB (Table 1). Procedures were performed in accordance with the
ethical standards of The Partners HealthCare Institutional Review Board which approved
this study and written informed consent was obtained from each patient. Punch biopsies
(~3–5μg total RNA content) were taken from the LV apex at two time points; immediately
after initiation of CPB at the time of routine placement of a surgical vent (pre-ischemic) and
after a median of 74 minutes (inter-quartile range 61–93min) (post-ischemia), during which
time the heart was arrested with cold blood cardioplegia for myocardial protection.
RNA sequencing
Tissue samples were immediately placed in RNAlater® (Ambion, Life Technologies, USA)
at +4C for 48 hours and then frozen at −80C until RNA extraction. Total RNA was isolated
with Trizol and RNA quality was assessed using the Agilent Bioanalyzer 2100 (Agilent,
Santa Clara, CA). Ribosomal RNA was removed by performing 1–2 washings of RNA
annealed to poly-T oligo beads (Invitrogen, Life technologies, Grand Island, NY). RNAs
were fragmented and then reverse transcribed using random hexamers (Invitrogen). Double-
stranded DNA (dsDNA) synthesis was performed using Pol I and RNA-ase H. Short
fragments were purified with QiaQuick PCR extraction kit (Qiagen, Hilden, Germany) and
resolved with EB buffer for end reparation and poly(A) addition followed by ligation with
sequencing adaptors for cluster generation and non-strand tagged sequencing on the Illumina
HiSeq 2000 (Illumina, San Diego, CA). Read length was 100 base pairs. Paired-end
sequencing produced on average 82 million reads per sample.
Alignment
Raw reads produced by the Illumina sequencer imaging files were filtered to remove reads
containing adaptor sequences, containing >5% unknown nucleotides, or having >50% of
reads with base quality scores < 5. Cleaned and trimmed mRNA reads were aligned to the
human reference genome (UCSC hg19) using Tophat version 2.0.5 under default settings12.
BAM files were subsequently sorted by chromosome number and converted to SAM files
using SAMtools.13 Reads were counted with HTSeq-count14 using the GENCODE release
1915 annotation file amended to include mitochondrial long noncoding RNAs found in the
NONCODE 2016 annotation file.16 As many lncRNAs overlap with coding regions in both
the sense and anti-sense orientation, the “union” default option for HTSeq-count was chosen
to avoid miscounting reads from mRNAs as lncRNAs.
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Differential expression
Read counts were subjected to paired differential expression analysis using the R17 package
DESeq2.18 Genes were considered significant if their log2 fold change (post-ischemic/pre-
ischemic) was >0.58 or <−0.58, their mean FPKM (fragments per kilobase per million
mapped reads) across all samples was greater than 0.01, and their p-value adjusted for
multiple comparison (Benjamini Hochberg) was <0.01 (Figure S1). The same methodology
was used for the subgroup analysis on diabetic and non-diabetic patients with each cohort
analyzed separately.
Neighboring coding gene enrichment analysis
All coding genes located within 100 kb (kilobases) of each differentially expressed lncRNA
were considered neighboring. Identification of these genes was facilitated by the GREAT
database.19 Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG)
analysis was conducted using the R package clusterProfiler.20 The p-values are corrected for
multiple comparison using the Benjamini Hochberg method.
Co-expressed lncRNA-mRNA studies
The correlation between the expression of all differentially expressed lncRNAs and all
mRNAs from all 85 paired samples (170 samples total) was determined using Partek®
Genomics Suite™ (PGS) version 6.6 (Partek Inc., MO, USA). FPKM (fragments per
kilobase per million mapped reads) was used for mRNA and lncRNA expression. These
normalized values were obtained by extracting read counts from DESeq2 and gene lengths
from the annotation file using the R package GenomicFeatures21. Those coding genes with
absolute Spearman’s rank correlation coefficient greater than 0.7 were subjected to GO and
KEGG analysis with clusterProfiler as described above. Variance stabilized gene expression
values were obtained for all lncRNA and mRNAs in the annotation file using DESeq2. Fold
change (post-ischemic/pre-ischemic) was calculated for all RNAs from all 85 patients.
Spearman’s rank correlation coefficients for co-expressed lncRNAs and mRNAs, and
enrichment terms for mRNAs were then determined using similar methods described above.
A density plot was generated in JMP® Version 10 (SAS Institute Inc., Cary, NC) using
absolute Spearman’s rank correlation coefficients derived from the co-expression of each
lncRNA-neighboring coding gene pair compared to correlations from the co-expression of
randomly selected lncRNA-mRNA pairs. Significance was determined using a standard t-
test.
Transcription factor binding site enrichment analysis
Over-represented transcription factor binding sites was performed on the 2kb region
upstream from the transcriptional start site of all differentially expressed lncRNAs using the
TRANSFAC® database (www.biobase-international.com/transcription-factor-binding-sites
from BIOBASE Corporation).22 The background sequences were randomly generated and
default settings were used for all other parameters; the significance was set at a p-value <
0.01. Enrichment of E2F1 binding in HeLa-S3 cells was extracted from publically available
peak calls through the ENCODE database.23
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Droplet Digital polymerase chain reaction (ddPCR™)
Validation of selected lncRNA and mRNA transcripts was performed on 12 pairs of pre-
ischemic and post-ischemic samples using the Bio-Rad QX100™ Droplet Digital PCR
(ddPCR™) system (Pleasanton, CA).24 cDNA was generated from patient samples as
described above. PCR reactions were constructed using custom probe and primer sequences
(Table S1) and absolute concentration of transcripts was obtained according to the
manufacturer’s specifications. Relative expression was calculated using the house keeping
gene tumor protein, translationally-controlled 1 (TPT1). Statistical significance was
determined using a paired t-test. Stripcharts and statistics were generated using the R
package ggplots2.25
Results
The landscape of lncRNA expression before and after ischemia
Our annotation file contained 13,871 lncRNAs. The most highly expressed lncRNAs in our
LV samples have previously been identified as highly expressed in other transcriptome
profiles of the human LV.8, 26 Over half of the top 15 abundant lncRNAs are located
between coding genes and include well known lncRNAs such as MALAT1, H19, NEAT1,
and DANCR (Table 2). H19, which has been shown to play a role in cardiac necrosis27, met
statistical significance for up-regulation following ischemia in our samples albeit with a low
fold change (log2 fold change 0.33).
Differential expression analysis between pre- and post-ischemic samples was performed
using a paired analysis. 128 lncRNAs with log2 fold change >0.58 or <−0.58 (which
corresponds to an absolute fold change >1.5) and adjusted p-value < 0.01 were designated as
significant (Table S2). Of these, 97 genes were up-regulated and 31 genes were down-
regulated after ischemia (Figure 1A). Correcting for ischemic time yielded similar results
(data not shown). LncRNAs are classified in the GENCODE annotation file according to
their location relative to coding genes. This classification includes: antisense transcripts
(long noncoding RNAs that overlap coding genes but are expressed from the opposite
strand), intronic (lncRNAs that overlap with intronic sequences of coding genes) sense
overlapping (lncRNAs that at least in part overlap with exons on the same strand as a coding
gene) and lincRNAs (located between coding genes). The majority of the differentially
expressed lncRNAs identified in this study were either antisense (44%) or lincRNAs (43%)
(Figure 1B). Furthermore, these lncRNAs were typically smaller in size (greater than 58%
were less than 1kb in length) and expressed at lower levels (70% had a mean FPKM across
all samples of <0.1) (Figure 1B) as compared to their coding gene counterparts. This is also
consistent with other profiles of human and mouse lncRNA expression in the heart.8, 28
Interestingly, for some differentially expressed lncRNAs the magnitude of fold change was
correlated with the extent of injury. For example, there is a significant correlation between
ischemic time and expression log2 fold change among all patients in this study for the
upregulated lncRNA RP11-64B16.4 (Spearman’s rank correlation coefficient 0.34 and p-
value 1.67×10−3). In fact, this relationship was stronger than the correlation between
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ischemic time and post-operative day 1 CKMB for all patients (Spearman’s rank correlation
coefficient 0.15 and p-value 0.18) (Figure 1C).
Neighboring coding genes function in the stress and immune response
Since many studies have demonstrated that lncRNAs can be co-expressed, regulate, and
share similar function as their neighboring coding genes, we analyzed the gene ontology
enrichment of all neighboring coding genes for all differentially expressed lncRNAs. We
chose a reference range of 100 kb for this analysis based on reports which have shown a
decrease in strength of expression correlations between lncRNAs and nearby mRNAs
beyond this range.29 Within 100 kb, we identified 277 unique coding genes. In the GO
category biological processes, these genes were significantly enriched in “hydrogen
peroxide metabolic process”, “response to stress”, “response to stimulus”, and “immune
system process”. In the GO category molecular function, these genes were significantly
associated with “serine-type endopeptidase activity” and “protein binding”. Finally, we also
looked at the KEGG pathway enrichment of neighboring genes and found an association
with “tight junctions” and “leukocyte transendothelial migration” (Figure 2A). These
findings are consistent with many other enrichment studies on direct mRNA transcriptomes
of ischemic hearts in human and animal models.30–32 Moreover, there is a high correlation
between the expression of lncRNAs and their neighboring mRNA pairs (Figure 2B). For
example, the expression of the down-regulated lncRNA RP11-171A24.3 and its neighboring
gene RORB have a strong positive correlation (Spearman’s rank correlation coefficient 0.79)
(Figure 2C).
mRNAs co-expressed with ischemic lncRNAs regulate metabolism and heart physiology
Co-expression studies with coding genes may also uncover potential functions of lncRNAs.
We thus generated a list of coding genes that were co-regulated with our pool of
differentially expressed lncRNAs. Associations were considered significant if the absolute
Spearman’s rank correlation coefficient was greater than 0.7, a threshold chosen based on
similar comparisons made by other groups.33, 34 Interestingly, only 6 out of the 128
differentially expressed lncRNAs had significant correlations with 215 unique coding genes
(Table S3). Even more, all 6 of these lncRNAs were down-regulated with ischemia, they
tended to have high levels of expression, and all of their relationships with coding genes
were positive (that is no significant correlations were uncovered with a down-regulated
lncRNA and an up-regulated mRNA). Several of these co-expressed coding genes have been
shown to play a role in myocardial ischemia including FEM1A35 (co-expressed with
RP3-527G5.1) and ADIPOQ36 (co-expressed with TRHDE-AS1). Even more, these two
particular coding genes were also significantly down-regulated following ischemia in our
study (log2 fold change −0.67 and −0.88 and adjusted p-value 1.14×10−12 and 4.29×10−07,
respectively). Another notable gene is PHACTR1 which is co-expressed with two lncRNAs,
RP3-527G5.1 and RP11-371M22.1. This gene was also significantly down-regulated in our
study although to a lesser degree than FEM1A and ADIPOQ (log2 fold change −0.51 and p-
value 1.95×10−13). PHACTR1 harbors an intronic SNP, rs12526453, which has been shown
in genome-wide association studies to be linked to myocardial ischemia and coronary artery
disease.37 In rats, PHACTR1 is also down-regulated following myocardial infarction and
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may play a role in regulating the relative expression of actin isoforms in the heart.38
ddPCR™ was used to confirm the differential expression of these transcripts (Figure 3A–E).
The functional categories of all co-expressed genes was further analyzed with gene ontology
analysis. In the GO category biological process, there were several terms linked to
metabolism and cardiac function (Figure 4A). In the GO category cellular component there
were several terms linked to components of the mitochondria and sarcomere (Figure 4B). In
the GO category molecular function, there were several terms linked to nucleotide binding
(Figure 4C). Finally, the top KEGG pathways associated with the co-expressed coding genes
were “dilated cardiomyopathy”, “adrenergic signaling”, “carbon metabolism”, “insulin
secretion”, and “citrate cycle” (Figure 4D). Once again these associations have been
demonstrated for ischemic mRNA profiles of the heart in many other studies.30–32, 39
We repeated these correlation studies by first obtaining variance stabilized gene expression
levels for all samples and then computing the fold change for each RNA species between
pre- and post-ischemic subjects. Subsequently, we re-ran our correlation matrix where the
fold change of each differentially expressed lncRNA is compared to the fold change of each
mRNA for all 85 patients. The candidate coding genes and enrichment results were highly
similar to the original correlation studies using FPKM calculated abundances from all 170
samples (Table S4).
Transcription factor binding site enrichment of differentially expressed lncRNAs is linked
to ischemic injury
Transcription factors play a central role in the changes in gene expression following a potent
stimulus such as ischemia. As a result, we sought to determine if there exists an over-
representative collection of conserved transcription factor binding sites in the differentially
expressed lncRNAs uncovered in this study. To this end, we chose the 2kb region upstream
of each lncRNA as the promoter region for this study. There were a total of 30 transcription
factors with significantly enriched binding sites compared to a random background
sequence. Among the list were E2F and XBP-1 which have been shown in prior studies to
play a role in ischemic/reperfusion injury40, 41, along with Myogenin (MYOG), which plays
a critical role in muscle development42 (Figure S2).
Discussion
In this study we describe the first lncRNA profile of acute ischemia in the human heart. Our
list of differentially expressed transcripts offers a unique and essential contribution to
previously described profiles in that our study involves a high number of paired left
ventricular samples from human subjects immediately following ischemic insult. This
design not only enabled us to make cross-species comparisons, but also permitted us to
refine candidate lncRNAs that may have bonafide significant functions in the pathology of
ischemia in the heart. According to the Genotype-Tissue Expression (GTEx) project and
NONCODE database, many of the top differentially expressed lncRNAs demonstrate
enriched expression in the heart compared to other tissues including: RP13-270P17.1,
RP11-371M22.1, RP11-517P14.2, RP11-968A15.2, and RP11-64B16.4. Furthermore, the
expression of three lncRNAs shown to be strongly correlated with coding genes in our
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study, namely RP11-517P14.2, RP3-527G5.1, and RP11-371M22.1, had the highest
expression in the heart compared to other tissues.16, 43 Also, the list of differentially
expressed lncRNAs lacked conservation. Of the 121 differentially expressed lncRNAs
identified in the NONCODE database, 79% were conserved in primates, but only 29% were
conserved in rodents and 1% in birds. These characteristics fit well with a predicted tissue
specific pattern of functional lncRNAs in the heart.2, 44
Among the top differentially expressed lncRNAs is the upregulated lncRNA
RP13-270P17.1. This lncRNA lies between the two myosin light chain genes MYL12A and
MYL12B. It overlaps portions of the MYL12A gene on the opposite strand and lies directly
upstream of the MYL12B transcriptional start site. As a result it is poised to regulate these
two muscle specific genes. The expression of this lncRNA was also highly enriched in the
heart in the GTEx database.43 SNORD3A had the highest fold change and lowest p-value in
our candidate gene list. It encodes a C/D box small nucleolar RNA and thus its upregulation
following ischemia could play a central role in RNA biogenesis during acute ischemia45.
Furthermore, RP11-64B16.4 was also strongly upregulated in our study. The expression of
this lncRNA is also highly enriched in heart tissue43. Even more, it is an anti-sense lncRNA
located within the HSPB8 gene. HSPB8 encodes a heat shock protein which has been shown
by others to promote potent cardioprotection following ischemia.46 As a result,
RP11-64B16.4 may have a similar function either through its regulation of HSPB8 or simply
through sharing its transcriptional machinery.
The expression of some lncRNAs, including the upregulated genes RP11-64B16.4 and
RP13-270P17.1, had stronger correlations to ischemic time than post-operative day 1
CKMB, a marker of ischemia commonly used in clinical practice. Interestingly,
RP13-270P17.1 was also shown to be up-regulated in failing human right ventricles
compared to non-failing donor tissue28. Even more, according to the GTEx project,
RP13-270P17.1 is expressed primarily in the heart and testes with very little expression in
whole blood.43 As a result, the presence of RP13-270P17.1 in blood in the setting of
symptoms of acute coronary syndrome could be highly suggestive of myocardial ischemia.
These findings are purely observational and not conclusive at this time. Further studies are
needed to validate the diagnostic potential of these lncRNAs.
Given the lack of conservation, smaller size, and limited knowledge of functional motifs, it
can be more difficult to predict functions of lncRNAs using a bioinformatic approach.
Nevertheless, many studies have demonstrated a tendency for lncRNAs to be co-expressed
with neighboring coding genes. Potential mechanisms to explain this phenomenon include
shared regulatory sequences or feed-forward/feed-back loops in the local environment where
the lncRNA directly regulates the expression of its neighbor.47 Ontology and pathway
analysis of neighboring genes from our experiment showed enrichment in categories that
resemble profiles of coding genes from many human and animal models of myocardial
ischemia.30–32, 39 This includes such categories as stress, tight junctions, and leukocyte
migration. The observation that those lncRNAs that changed acutely during ischemia are
located in close proximity to coding genes that define the signature of myocardial infarction,
suggests that these lncRNAs could function as early initiators of transcriptional regulation
triggered by this insult. This is supported by the correlated expression between many
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neighboring coding genes and their lncRNA neighbors. Even more, transcription factor
binding site enrichment of these lncRNAs demonstrated an over-representation of
transcription factors known to play a role in ischemia/reperfusion injury, including E2F
family members and XBP-1. Publically available Chip-seq data from the ENCODE project
for E2F1 binding in HeLa-S3 cells demonstrated peaks in the promoter region of 3
differentially expressed lncRNAs: RP11-968A15.2, RP13-895J2.7, and RP11-517P14.2.23
Of note, expression of the lincRNA RP11-517P14.2 is highly correlated with coding genes
in our study. RP11-517P14.2 was also identified as being up-regulated in human hearts with
ischemic cardiomyopathy compared to healthy donor hearts.8
We also investigated the pool of coding genes in our samples that were co-expressed with all
differentially expressed lncRNA. Ontology and pathway analysis of these highly correlated
coding genes were similarly enriched in categories linked to myocardial infarction including
several metabolic pathways and functions specific to cardiomyocytes. One possible
explanation for the function of these co-expressed lncRNAs includes operating as
competitive inhibitors of miRNAs.4 This function would also fit with the tendency for
lncRNAs to be preferentially positively correlated instead of negatively correlated with
mRNAs, a pattern which has been demonstrated by other studies29. Moreover, according to
the miRcode48 database, many of the differentially expressed lncRNAs identified here are
predicted to interact with many miRNAs that have been implicated in the regulation of
myocardial ischemia including miR-1, miR-15, miR-21, miR-24, miR-34, miR-133, and
miR-199a49 (data not shown). The consequences of these interactions in the ischemia
phenotype require further investigation.
Future studies will be directed at validating these differentially expressed lncRNAs and
determining if the degree of their expression changes following ischemia is affected by
conditions such as coronary artery disease, gender, and diabetes. For example, a subgroup
analysis on patients with and without diabetes identified 81 lncRNAs with changes in
expression following ischemia that may depend on the glycemic environment of the patient
(Table S5 and S6).
Since our ischemic time was a median of 74 minutes, there may not have been enough
damage or time to allow for large changes in gene expression. Furthermore, by adding a fold
change cutoff we may also be excluding those lncRNAs that have significant functions yet
small changes in expression. These characteristics of the experimental design may increase
the number of false negatives. Nevertheless, we focused our attention on those lncRNAs
with the most robust changes in gene expression in order to limit the number of false
positives and thus improve the accuracy of our functional predictions, which can be quite
difficult for lncRNAs. We would also like to mention that due to the experimental design,
non polyadenylated lncRNAs cannot be analyzed in this current study and thus future work
will have to be done to provide a comprehensive description of the lncRNA pool of the
human left ventricle. Regardless of this caveat, we uncovered many lncRNAs with potential
functional roles downstream of the ischemic-reperfusion pathway.
In conclusion, we present the first lncRNA profile of the human LV following the early
stages of ischemia. This profile may have utility in predicting the extent of myocardial
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injury and can be used to describe several potential mechanisms of interaction between
lncRNAs and the coding genes that define the ischemic signature. Further studies, both in
humans and in animal models, will help validate the functional significance of these
candidate noncoding transcripts.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Clinical Perspective
Advances in genomic technology have led to the classification of a novel set of RNA
transcripts that do not encode proteins, namely long noncoding RNAs (lncRNAs). The
expression of these lncRNAs tends to be highly tissue and disease specific. The discovery
of differentially expressed lncRNAs in the human heart following acute ischemia may
lead to novel diagnostic and therapeutic targets for ischemic heart disease.
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Figure 1.
A. Volcano plot of all lncRNAs which depicts log2 fold change versus −log10 adjusted p-
value (padj). Significant differentially expressed genes are located between the vertical and
horizontal dotted lines and are highlighted in purple. B. Gene classification, length, and
abundance distribution of all differentially expressed lncRNAs. C. Scatter plot of log2 fold
change expression of RP11-64B16.4 versus ischemic time (in minutes).
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Figure 2.
A. Neighboring gene enrichment by Gene Ontology (GO) biological process, GO molecular
function, and KEGG pathway. Terms are ranked by significance using -log10 adjusted p-
value. B. Density plot comparing the Spearman’s rank correlation coefficients from the
expression of all neighboring lncRNA-mRNA pairs with the coefficients from the
expression of a random selection of lncRNA-mRNA pairs. p-value denotes a standard t-test.
C. Correlation of expression between the lncRNA RP11-171A24.3 and its neighboring gene
RORB. FPKM=fragments per kilobase per million mapped reads.
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Figure 3.
Droplet Digital PCR of A.) RP3.527G5.1 B.) RP11.171A24.3 C.) RP11.371M22.1 D.)
FEM1A E.) PHACTR1 on 12 paired pre- and post-ischemic samples. p-value was generated
from a paired t-test.
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Figure 4.
Over-represented Gene Ontology (GO) biological process (A), GO cellular component (B),
GO molecular function (C), and KEGG pathway (D) terms of genes with mRNA expression
that is highly correlated with the expression of differentially expressed lncRNAs. Terms are
ranked by significance using −log10 adjusted p-value.
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Table 1
Patient demographics and clinical characteristics (N=85)
Demographic Statistic
Age (years) 71 (64–81)*
Male gender 51 (60)†
Caucasian Descent 84 (99)†
BMI (kg/m2) 30 (26–34)*
Diabetes 37 (44)†
CAD 40 (47)†
Post-operative Day 1 CKMB (μg/L) 26.95 (22.4–34.0)*
Aortic cross-clamp (minutes) 74 (61–93)*
LV ejection fraction (%) 60 (55–65)*
*
Median value (inter-quartile range)
†
Number of patients (percent of patients)
BMI: body mass index; CAD: coronary artery disease; CKMB: creatine kinase MB fraction; LV: left ventricle)
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Table 2
Top 15 most abundant lncRNAs
LncRNA Mean FPKM Chromosome Strand
NONHSAG053897.1 956.9 chrM +
MALAT1 378 chr11 +
H19 99.8 chr11 −
RP3-527G5.1 51.9 chr6 −
LINC00657 46.4 chr20 −
NEAT1 42.1 chr11 +
RP11-480G7.1 26.3 chr16 −
RP11-553L6.5 20.1 chr3 −
AC053503.6 19.9 chr2 −
RP11-532N4.2 15.1 chr6 +
CTD-2083E4.7 12.8 chr5 +
DANCR 12.6 chr4 +
RP11-264A11.1 11.8 chr10 −
LINC00984 10.4 chr15 +
RP11-432J24.5 10.3 chr10 −
lncRNA: long noncoding RNA; FPKM: fragments per kilobase per million mapped reads
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